How does accounting for bearer plants differ from that for other biological assets?

Multiple Choice

Companies treat bearer plants as PPE. Thus, they choose between the cost and revaluation models for these assets. The treatment of bearer plants constitutes an important exception to the requirement that companies revalue biological assets.

Companies always revalue bearer plants, as they are required to do for all other biological assets.

Companies treat bearer plants as goodwill.

Companies never revalue bearer plants, because of their nature.